Bayer Aktiengesellschaft

Aicuris Gmbh & Co. Kg

Bayer Healthcare Aktiengesellschaft

Bayer Pharma Aktiengesellschaft

Rainer Endermann

Uwe Petersen

Karl G Metzger

Thomas Schenke

Klaus Grohe

Klaus-Dieter Bremm

Hans-Joachim Zeiler

Ingo Haller

Andreas Krebs

Michael Schriewer

Stephan Bartel

Klaus Dieter Bremm

Hein-Peter Kroll

Dieter Habich

Bernd Riedl

Andreas Stolle

Thomas Jaetsch

Hanno Wild

Nina Brunner

Harald Labischinski

Thomas Himmler

Joachim Schuhmacher

Klaus Schaller

Karl-Georg Metzger

Burkhard Mielke

Heinz-Georg Wetzstein

Guido Schiffer

Hans-Otto Werling

Michael Stegemann

Martin Ruppelt

Thomas Philipps

Joachim Telser

Sonja Anlauf

Niels Svenstrup

Franz Von Nussbaum

Jacques Ragot

Franz Kunisch

Elke Hartmann

Walter Guarnieri

Siegfried Raddatz

Thomas Lampe

Hans-Christian Militzer

Michael Matzke

Chantal Fuerstner

Michael-Alexander Bruening

Manfred Plempel

Werner Hallenbach

Joachim Mittendorf

Christoph Freiberg

Ben Newton

Franz Pirro

Yolanda Cancho-Grande

Michael Ruther

Gunter Schmidt

Josef Pernerstorfer

Wilfried Schrock

Martin Scheer

Peter Nell

Jens Pohlmann

Stefan Weigand

Holger Paulsen

Mitsuyuki Shimada

Stephan Schneider

Martin Michels

Michael Otteneder

Kerstin Ehlert

Hermann Hagemann

Bernd Baasner

Mazen Es-Sayed

Rolf Grosser

Wolfgang Hartwig

Markus Kordes

Kerstin Henninger

Johannes Köbberling

Hartmut Beck

Wolfgang Springer

Armin De Meijere

Isabelle Adelt

Susanne Greschat

Johannes Koebberling

Andreas Schumacher

Dieter H Abich

Berthold Hinzen

Joachim Kr&uuml;ger

Stefan B Ohm

Werner Schroeder

Reinhold Gahlmann

Dieter H&auml;bich

Michael Brands

Frank-Ulrich Geschke

Vladimir N Belov

Victor Sokolov

Sergej Kozhushkov

Christoph Ladel

Hans-Rudolf Pfaendler

Wolfgang Hartiwg

Uwe Peterson

Stephen Bartel

Heike Brötz-Oesterhelt

Veronika Hellwig

The invention relates to lysobactin amides and methods for their preparation, as well as their use for manufacturing medicaments for the treatment and/or prophylaxis of diseases, in particular bacterial infectious diseases.

Lysobactin amides

The invention relates to inhalable quinolonecarboxylic acid derivative compositions for local control of diseases of the respiratory organs, in particular of lung diseases.

Treatment of bacterial diseases of the respiratory organs

The invention relates to nonadepsipeptides and methods for their preparation and their use for the production of medicaments for the treatment and/or prophylaxis of diseases, in particular bacterial infectious diseases.

Substituted nonadepsipeptides

Nonadepsipeptides and methods for their preparation and their use for the production of medicaments for the treatment and/or prophylaxis of diseases, in particular bacterial infectious diseases are described.

Deoxonadepsipeptides

The invention relates to cyclic nonapeptide amides and to methods for their preparation and to their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially bacterial infectious diseases.

Cyclic nonapeptide amides

The invention relates to antibacterial macrocycles with substituted biphenyl and processes for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the production of medicaments for the treatment and/or prophylaxis of diseases, especially of bacterial infections.

Antibacterial macrocycles with substituted biphenyl

The invention relates to nonadepsipeptides and processes for their preparation, and to their use for producing medicaments for the treatment and/or prophylaxis of diseases, in particular bacterial infectious diseases.

Acylated nonadepsipeptides containing pyridyl alanine residues

The invention relates to antibacterial amide macrocycles and processes for their preparation, their use for the treatment and/or prophylaxis of diseases and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially bacterial infections.

Antibacterial amide macrocycles IV

The present invention relates to compounds of the general formula (I), processes for their preparation, pharmaceutical compositions comprising them, and their use in the treatment of diseases in humans or animals. 

Antibacterial macrocycles

The present invention relates to compounds, to processes for preparing them, to pharmaceutical compositions comprising them, and to their use in the therapy and/or prophylaxis in illnesses in people or animals, especially diseases of bacterial infection.

Cinnamic acid amides

The invention relates to nonadepsipeptides and process for their preparation, and to their use for producing medicaments for the treatment and/or prophylaxis of diseases, in particular bacterial infectious diseases.

Acylated nonadepsipeptides

The present invention relates to compounds, to processes for preparing them, to pharmaceutical compositions comprising them, and to their use in the therapy and/or prophylaxis of diseases in people or animals, especially diseases of bacterial infection.

Arylamides

Tan-1057 derivatives

The invention relates to the use of quinolone- and naphthyridonecarboxylic acid derivatives which are substituted in position 7 by a 1-aminomethyl-2-oxa-7-azabicyclo&lsqb;3.3.0&rsqb;oct-7-yl radical, and of their salts for the therapy of,infections and associated gastroduodenal disorders.

Use of 7-(1-aminomethyl-2-oxa-7-aza-bicyclo&lsqb;3.3.0&rsqb;oct-7-yl)-quinolone carboxylic acid and naphthyridone carboxylic acid derivatives for treating Helicobacter pylori infections and the gastroduodenal diseases associated therewith

The invention relates to heteroatom-containing benzocyclopentaneoxazolidinones, to processes for their preparation and their use as medicaments, especially as antibacterial medicaments.

Heteroatom-containing benzocyclopentane-oxazolidinones

Growing community of inventors

Wuppertal, Germany

Rainer Endermann